We'll have to agree to disagree there - if you want to track the trajectory of the underlying business, especially when one-off non-cash expenses are being booked, EBIT is the only way to go.
"Competitor snapping at the heels"?? BEACON is a P2 study which only initiated this month so that compound is still 3-4 years away from approval, if it makes it at all.
We'll have to agree to disagree there - if you want to track the...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.93 |
Change
-0.235(1.55%) |
Mkt cap ! $752.6M | |||
| Open | High | Low | Value | Volume |
| $15.20 | $15.20 | $14.81 | $343.7K | 22.94K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 75 | $14.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.95 | 173 | 10 |
View Market Depth
| Last trade - 11.33am 18/09/2024 (20 minute delay) ? |
| CUV (ASX) Chart |